Overview

The Addition of Montelukast to Fluticasone in the Treatment of Perennial Allergic Rhinitis

Status:
Terminated
Trial end date:
2009-01-01
Target enrollment:
Participant gender:
Summary
Some people with nasal allergy symptoms continue to have symptoms even after treatment with a nasal steroid spray. The purpose of this study is to see if these patients are helped by adding another medication (montelukast) to their treatment compared to placebo (a substance that looks like the active medication but does not contain the drug).
Phase:
Phase 4
Details
Lead Sponsor:
University of Chicago
Collaborator:
Merck Sharp & Dohme Corp.
Treatments:
Fluticasone
Montelukast
Xhance